Secretion of recombinant human fibrinogen by the murine mammary gland

Stephen Butler, Tanya O'Sickey, Susan Lord, Henryk Lubon, Francis Gwazdauskas, William Velander

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Transgenic animals secreting individual chains and assembled fibrinogen were produced to evaluate the capacity of the mammary gland for maximizing assembly, glycosylation and secretion of recombinant human fibrinogen (rhfib). Transgenes were constructed from the 4.1kbp murine Whey Acidic Protein promoter (mWAP) and the three cDNAs coding for the Aα, Bβ and γ fibrinogen chains. Transgenic mice secreted fully assembled fibrinogen into milk at concentrations between 10 and 200 μg/ml, with total secretion of subunits approaching 700 μg/ml in milk. Partially purified fibrinogen was shown to form a visible and stable clot after treatment with human thrombin and factor XIII. The level of assembled fibrinogen was proportional to the lowest amount of subunit produced where both the Bβ and γ chains were rate limiting. Both the Bβ and γ chains were glycosylated when co-expressed and the degree of saccharide maturation was dependent on expression level, with processing preferred for γ chains over Bβ chains. Also, the subunit complexes γ 2, A αγ2 and the individual subunits Aα, Bβ and γ were found as secretion products. When the Bβ was secreted individually, the glycosylation profile of the molecule was of a mature complex saccharide indicating recognition of the molecule by the glycosylation pathway without association with other fibrinogen chains. To date secretion of Bβ chain has been not observed in any cell type, suggesting that the secretion pathway in mammary epithelia is less restrictive than that occurring in hepatocytes and other cells previously used to study fibrinogen assembly.

Original languageEnglish (US)
Pages (from-to)437-450
Number of pages14
JournalTransgenic Research
Volume13
Issue number5
DOIs
StatePublished - Oct 1 2004

Fingerprint

fibrinogen
Human Mammary Glands
mammary glands
Fibrinogen
secretion
mice
glycosylation
Glycosylation
Milk
carbohydrates
Factor XIII
milk
transgenic animals
Genetically Modified Animals
thrombin
Secretory Pathway
whey
Transgenes
varespladib methyl
Thrombin

Keywords

  • Mammary gland expression
  • Recombinant human fibrinogen
  • Transgenic mouse
  • WAP promoter

ASJC Scopus subject areas

  • Biotechnology
  • Animal Science and Zoology
  • Agronomy and Crop Science
  • Genetics

Cite this

Secretion of recombinant human fibrinogen by the murine mammary gland. / Butler, Stephen; O'Sickey, Tanya; Lord, Susan; Lubon, Henryk; Gwazdauskas, Francis; Velander, William.

In: Transgenic Research, Vol. 13, No. 5, 01.10.2004, p. 437-450.

Research output: Contribution to journalArticle

Butler, S, O'Sickey, T, Lord, S, Lubon, H, Gwazdauskas, F & Velander, W 2004, 'Secretion of recombinant human fibrinogen by the murine mammary gland', Transgenic Research, vol. 13, no. 5, pp. 437-450. https://doi.org/10.1007/s11248-004-9589-8
Butler, Stephen ; O'Sickey, Tanya ; Lord, Susan ; Lubon, Henryk ; Gwazdauskas, Francis ; Velander, William. / Secretion of recombinant human fibrinogen by the murine mammary gland. In: Transgenic Research. 2004 ; Vol. 13, No. 5. pp. 437-450.
@article{2eb1df282b274d4d86a8ac5aa1725470,
title = "Secretion of recombinant human fibrinogen by the murine mammary gland",
abstract = "Transgenic animals secreting individual chains and assembled fibrinogen were produced to evaluate the capacity of the mammary gland for maximizing assembly, glycosylation and secretion of recombinant human fibrinogen (rhfib). Transgenes were constructed from the 4.1kbp murine Whey Acidic Protein promoter (mWAP) and the three cDNAs coding for the Aα, Bβ and γ fibrinogen chains. Transgenic mice secreted fully assembled fibrinogen into milk at concentrations between 10 and 200 μg/ml, with total secretion of subunits approaching 700 μg/ml in milk. Partially purified fibrinogen was shown to form a visible and stable clot after treatment with human thrombin and factor XIII. The level of assembled fibrinogen was proportional to the lowest amount of subunit produced where both the Bβ and γ chains were rate limiting. Both the Bβ and γ chains were glycosylated when co-expressed and the degree of saccharide maturation was dependent on expression level, with processing preferred for γ chains over Bβ chains. Also, the subunit complexes γ 2, A αγ2 and the individual subunits Aα, Bβ and γ were found as secretion products. When the Bβ was secreted individually, the glycosylation profile of the molecule was of a mature complex saccharide indicating recognition of the molecule by the glycosylation pathway without association with other fibrinogen chains. To date secretion of Bβ chain has been not observed in any cell type, suggesting that the secretion pathway in mammary epithelia is less restrictive than that occurring in hepatocytes and other cells previously used to study fibrinogen assembly.",
keywords = "Mammary gland expression, Recombinant human fibrinogen, Transgenic mouse, WAP promoter",
author = "Stephen Butler and Tanya O'Sickey and Susan Lord and Henryk Lubon and Francis Gwazdauskas and William Velander",
year = "2004",
month = "10",
day = "1",
doi = "10.1007/s11248-004-9589-8",
language = "English (US)",
volume = "13",
pages = "437--450",
journal = "Transgenic Research",
issn = "0962-8819",
publisher = "Springer Netherlands",
number = "5",

}

TY - JOUR

T1 - Secretion of recombinant human fibrinogen by the murine mammary gland

AU - Butler, Stephen

AU - O'Sickey, Tanya

AU - Lord, Susan

AU - Lubon, Henryk

AU - Gwazdauskas, Francis

AU - Velander, William

PY - 2004/10/1

Y1 - 2004/10/1

N2 - Transgenic animals secreting individual chains and assembled fibrinogen were produced to evaluate the capacity of the mammary gland for maximizing assembly, glycosylation and secretion of recombinant human fibrinogen (rhfib). Transgenes were constructed from the 4.1kbp murine Whey Acidic Protein promoter (mWAP) and the three cDNAs coding for the Aα, Bβ and γ fibrinogen chains. Transgenic mice secreted fully assembled fibrinogen into milk at concentrations between 10 and 200 μg/ml, with total secretion of subunits approaching 700 μg/ml in milk. Partially purified fibrinogen was shown to form a visible and stable clot after treatment with human thrombin and factor XIII. The level of assembled fibrinogen was proportional to the lowest amount of subunit produced where both the Bβ and γ chains were rate limiting. Both the Bβ and γ chains were glycosylated when co-expressed and the degree of saccharide maturation was dependent on expression level, with processing preferred for γ chains over Bβ chains. Also, the subunit complexes γ 2, A αγ2 and the individual subunits Aα, Bβ and γ were found as secretion products. When the Bβ was secreted individually, the glycosylation profile of the molecule was of a mature complex saccharide indicating recognition of the molecule by the glycosylation pathway without association with other fibrinogen chains. To date secretion of Bβ chain has been not observed in any cell type, suggesting that the secretion pathway in mammary epithelia is less restrictive than that occurring in hepatocytes and other cells previously used to study fibrinogen assembly.

AB - Transgenic animals secreting individual chains and assembled fibrinogen were produced to evaluate the capacity of the mammary gland for maximizing assembly, glycosylation and secretion of recombinant human fibrinogen (rhfib). Transgenes were constructed from the 4.1kbp murine Whey Acidic Protein promoter (mWAP) and the three cDNAs coding for the Aα, Bβ and γ fibrinogen chains. Transgenic mice secreted fully assembled fibrinogen into milk at concentrations between 10 and 200 μg/ml, with total secretion of subunits approaching 700 μg/ml in milk. Partially purified fibrinogen was shown to form a visible and stable clot after treatment with human thrombin and factor XIII. The level of assembled fibrinogen was proportional to the lowest amount of subunit produced where both the Bβ and γ chains were rate limiting. Both the Bβ and γ chains were glycosylated when co-expressed and the degree of saccharide maturation was dependent on expression level, with processing preferred for γ chains over Bβ chains. Also, the subunit complexes γ 2, A αγ2 and the individual subunits Aα, Bβ and γ were found as secretion products. When the Bβ was secreted individually, the glycosylation profile of the molecule was of a mature complex saccharide indicating recognition of the molecule by the glycosylation pathway without association with other fibrinogen chains. To date secretion of Bβ chain has been not observed in any cell type, suggesting that the secretion pathway in mammary epithelia is less restrictive than that occurring in hepatocytes and other cells previously used to study fibrinogen assembly.

KW - Mammary gland expression

KW - Recombinant human fibrinogen

KW - Transgenic mouse

KW - WAP promoter

UR - http://www.scopus.com/inward/record.url?scp=7244238182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7244238182&partnerID=8YFLogxK

U2 - 10.1007/s11248-004-9589-8

DO - 10.1007/s11248-004-9589-8

M3 - Article

C2 - 15587268

AN - SCOPUS:7244238182

VL - 13

SP - 437

EP - 450

JO - Transgenic Research

JF - Transgenic Research

SN - 0962-8819

IS - 5

ER -